933 related articles for article (PubMed ID: 11287583)
41. Gene transfer using a disabled herpes virus vector containing the EMCV IRES allows multiple gene expression in vitro and in vivo.
Wagstaff MJ; Lilley CE; Smith J; Robinson MJ; Coffin RS; Latchman DS
Gene Ther; 1998 Nov; 5(11):1566-70. PubMed ID: 9930311
[TBL] [Abstract][Full Text] [Related]
42. The transcriptional activation domain of VP16 is required for efficient infection and establishment of latency by HSV-1 in the murine peripheral and central nervous systems.
Tal-Singer R; Pichyangkura R; Chung E; Lasner TM; Randazzo BP; Trojanowski JQ; Fraser NW; Triezenberg SJ
Virology; 1999 Jun; 259(1):20-33. PubMed ID: 10364486
[TBL] [Abstract][Full Text] [Related]
43. Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector.
Watanabe D; Brockman MA; Ndung'u T; Mathews L; Lucas WT; Murphy CG; Felber BK; Pavlakis GN; Deluca NA; Knipe DM
Virology; 2007 Jan; 357(2):186-98. PubMed ID: 16996101
[TBL] [Abstract][Full Text] [Related]
44. Gene delivery using herpes simplex virus vectors.
Burton EA; Fink DJ; Glorioso JC
DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
[TBL] [Abstract][Full Text] [Related]
45. Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector.
Zhu J; Kang W; Wolfe JH; Fraser NW
Mol Ther; 2000 Jul; 2(1):82-94. PubMed ID: 10899831
[TBL] [Abstract][Full Text] [Related]
46. Gene delivery to rat enteric neurons using herpes simplex virus-based vectors.
Howard MK; Coffin RS; Maclean AR; Brown SM; Bailey D; Anderson PN; Burnstock G; Latchman DS
J Mol Neurosci; 1997 Oct; 9(2):65-74. PubMed ID: 9407388
[TBL] [Abstract][Full Text] [Related]
47. Herpes simplex virus-mediated gene delivery to the rodent visual system.
Spencer B; Agarwala S; Miskulin M; Smith M; Brandt CR
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1392-401. PubMed ID: 10798655
[TBL] [Abstract][Full Text] [Related]
48. Herpes simplex virus latency-associated transcript encodes a protein which greatly enhances virus growth, can compensate for deficiencies in immediate-early gene expression, and is likely to function during reactivation from virus latency.
Thomas SK; Gough G; Latchman DS; Coffin RS
J Virol; 1999 Aug; 73(8):6618-25. PubMed ID: 10400759
[TBL] [Abstract][Full Text] [Related]
49. High-mobility group protein A1 binds herpes simplex virus gene regulatory sequences and affects their expression.
Matta MK; Panagiotidis CA
Arch Virol; 2008; 153(7):1251-62. PubMed ID: 18506571
[TBL] [Abstract][Full Text] [Related]
50. The herpes simplex virus type 1 immediate-early protein ICP0 is necessary for the efficient establishment of latent infection.
Wilcox CL; Smith RL; Everett RD; Mysofski D
J Virol; 1997 Sep; 71(9):6777-85. PubMed ID: 9261402
[TBL] [Abstract][Full Text] [Related]
51. Modest increases in the titers of helper virus-free herpes simplex virus 1 (HSV-1) vectors by packaging in a cell line with inducible expression of HSV-1 VP16 or by treatment with N,N'-hexamethylene-bis-acetamide.
Sun M; Lee J; Yu L; Geller AI
Acta Virol; 2000 Dec; 44(6):365-9. PubMed ID: 11332280
[TBL] [Abstract][Full Text] [Related]
52. Deletion of the S component inverted repeat sequence c' and the nonessential genes U(S)1 through U(S)5 from the herpes simplex virus type 1 genome substantially impairs productive viral infection in cell culture and pathogenesis in the rat central nervous system.
Rasty S; Poliani PL; Fink DJ; Glorioso JC
J Neurovirol; 1997 Aug; 3(4):247-64. PubMed ID: 9291233
[TBL] [Abstract][Full Text] [Related]
53. Replication-Competent Controlled Herpes Simplex Virus.
Bloom DC; Feller J; McAnany P; Vilaboa N; Voellmy R
J Virol; 2015 Oct; 89(20):10668-79. PubMed ID: 26269179
[TBL] [Abstract][Full Text] [Related]
54. Improved packaging system for generation of high-level noncytotoxic HSV-1 amplicon vectors using Cre-loxP site-specific recombination to delete the packaging signals of defective helper genomes.
Zaupa C; Revol-Guyot V; Epstein AL
Hum Gene Ther; 2003 Jul; 14(11):1049-63. PubMed ID: 12885345
[TBL] [Abstract][Full Text] [Related]
55. Expression from the herpes simplex virus type 1 latency-associated promoter in the murine central nervous system.
Smith C; Lachmann RH; Efstathiou S
J Gen Virol; 2000 Mar; 81(Pt 3):649-62. PubMed ID: 10675402
[TBL] [Abstract][Full Text] [Related]
56. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells.
Johnston KM; Jacoby D; Pechan PA; Fraefel C; Borghesani P; Schuback D; Dunn RJ; Smith FI; Breakefield XO
Hum Gene Ther; 1997 Feb; 8(3):359-70. PubMed ID: 9048203
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of herpes simplex virus type 1 immediate-early gene expression by alpha interferon is not VP16 specific.
Nicholl MJ; Preston CM
J Virol; 1996 Sep; 70(9):6336-9. PubMed ID: 8709261
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of infection parameters in the production of replication-defective HSV-1 viral vectors.
Ozuer A; Wechuck JB; Russell B; Wolfe D; Goins WF; Glorioso JC; Ataai MM
Biotechnol Prog; 2002; 18(3):476-82. PubMed ID: 12052062
[TBL] [Abstract][Full Text] [Related]
59. Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro.
Arthur JL; Scarpini CG; Connor V; Lachmann RH; Tolkovsky AM; Efstathiou S
J Virol; 2001 Apr; 75(8):3885-95. PubMed ID: 11264377
[TBL] [Abstract][Full Text] [Related]
60. Herpes simplex virus type 1 vector mediated gene transfer to muscle.
Huard J; Goins WF; Glorioso JC
Gene Ther; 1995 Aug; 2(6):385-92. PubMed ID: 7584113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
